胃肠病学和肝病学杂志2024,Vol.33Issue(7) :926-929.DOI:10.3969/j.issn.1006-5709.2024.07.025

硫唑嘌呤在自身免疫性肝病中的应用研究进展

Advances in the application of Azathioprine in autoimmune liver disease

陈洁 王雪 汤善宏
胃肠病学和肝病学杂志2024,Vol.33Issue(7) :926-929.DOI:10.3969/j.issn.1006-5709.2024.07.025

硫唑嘌呤在自身免疫性肝病中的应用研究进展

Advances in the application of Azathioprine in autoimmune liver disease

陈洁 1王雪 2汤善宏2
扫码查看

作者信息

  • 1. 成都医学院临床医学院,四川成都 610500
  • 2. 中国人民解放军西部战区总医院消化内科
  • 折叠

摘要

自身免疫性肝病(autoimmune liver disease,AILD)主要是免疫功能障碍所引起的一类慢性肝病,免疫抑制治疗是AILD的主要药物治疗方案,而硫唑嘌呤在AILD中应用广泛,本文介绍了硫唑嘌呤在AILD中的作用机制,同时归纳了在AILD中包括自身免疫性肝炎、原发性胆汁性胆管炎、原发性硬化性胆管炎、IgG4相关性硬化性胆管炎,以及重叠综合症等各个疾病中的具体应用,总结该药物临床应用的不良反应以及应用的局限性,为临床AILD的治疗提供思路.

Abstract

Autoimmune liver disease(AILD)is a special type of chronic liver disease caused by immune dysfunc-tion.Immunosuppressive therapy is the main drug treatment for AILD,and Azathioprine is widely used in AILD among immunosuppressive agents.This paper introduced the mechanism of action of Azathioprine in AILD.At the same time,the specific applications in AILD including autoimmune hepatitis,primary biliary cirrhosis,primary sclerosing cholangi-tis,IgG4-related sclerosing cholangitis,overlapping syndrome and other diseases were summarized.The side effects and limitations of the clinical application of this drug were summarized,providing ideas for clinical treatment of AILD.

关键词

自身免疫性肝病/硫唑嘌呤/药物疗法/治疗

Key words

Autoimmune liver disease/Azathioprine/Drug therapy/Therapy

引用本文复制引用

出版年

2024
胃肠病学和肝病学杂志
郑州大学

胃肠病学和肝病学杂志

CSTPCD
影响因子:1.029
ISSN:1006-5709
段落导航相关论文